Popping up today,
shaping tomorrow.

Empowering Visionaries in HealthcarE

Innovators Pop-Up was born out of the idea that early innovators need a space dedicated to showcasing their technology that allows for connection with key industry influencers, provides a compelling and memorable experience for attendees, and delivers enduring impact.

Empowering Visionaries in HealthcarE

Innovators Pop-Up was born out of the idea that early innovators need a space dedicated to showcasing their technology that allows for connection with key industry influencers, provides a compelling and memorable experience for attendees, and delivers enduring impact.

Immerse
yourself in
INNOVATION

chicago | October 17, 2024

6:00 – 9:00 PM
Row 24
Drinks + Hors d’oeuvres

2411 S Michigan Ave, Chicago, IL 60616

Register

JOIN US IN THE INNOVATION PLAYGROUND

This dynamic and immersive event will showcase cutting-edge healthcare innovations in an interactive “playground.” Dive into a world where groundbreaking ophthalmology meets hands-on exploration, fostering connections and sparking revolutionary ideas.

Get HANDS-ON with the
latest technologies in
ophthalmology

Connect with industry
leaders and fellow
visionaries

Champion innovators as
they take the “hot seat”
where they’ll be
interviewed by key
industry leaders

Learn More »

Be part of shaping the
next wave of ophthalmic
advancements

ready to showcase
your healthcare technology?

INNOVATOR

SHOWCASED INNOVATORS

Sponsors

Want to support the innovator ecosystem?

Sponsor

Powered By:

iDoc Social Logo
© 2024 Innovators Pop-up. All rights reserved.
Linkedin-in

Myra Vision

BIO

Seeking to answer the need for personalized glaucoma care, Myra Vision is developing the Calibreye™ Titratable Glaucoma TherapyTM (TGT) Surgical System—the next-generation solution designed for patients with glaucoma who require low intraocular pressure (IOP).

The Calibreye TGT Surgical System aims to:

  • Personalize glaucoma care by enabling adjustable outflow control
  • Provide a safe solution to IOP reduction by using biocompatible materials that conform to the eye
  • Enhance the confidence of ophthalmologists during implantation, by leveraging the well-established method of ab externo delivery
  • Reverse hypotony due to excessive flow with an adjustable feature built into its innovative design


As an unprecedented development in glaucoma care, the Calibreye TGT System is designed to improve outcomes and minimize complications associated with conventional approaches.

The Calibreye TGT Surgical System is for investigational use only and is not for sale in the US or outside the US.

Oculotix

BIO

Oculotix is applying AI-based software to optimize intraocular lens (IOL) model selection to improve patient vision outcomes and boost surgical efficiency in cataract and lens exchange procedures. The software provides surgeons with predictive analytics of vision outcomes and a recommended IOL model to achieve the best possible outcome for their patients.

Vision outcomes are predicted and compared to the patient’s expectations for day/night driving, spectacle-independence, and potential visual artifacts. This information provides the surgeon and patient with a quantitative pre-operative assessment, increasing the likelihood of patient satisfaction with surgical outcomes while also saving clinical time and resources. The software is particularly useful in boosting confidence in adoption of advanced technology IOLs, which can have benefits for patients well suited to the technologies available.

Bausch + Lomb

BIO

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on X, LinkedIn, Facebook and Instagram.

True North

BIO

True North Contract Research is a dynamic and rapidly growing Contract Research Organization (CRO) specializing in Ophthalmology research. We strive to deliver an experience that is second to none to our sponsor partners and site partners. Our longstanding commitment to advancing the field of ophthalmology through clinical research has provided us with the experience to execute trials efficiently with a focus on accuracy and compliance. We merge FDA and clinical site perspectives to identify effective solutions that are agreeable to both parties and then mitigate roadblocks to achieve trial endpoints. One of our greatest strengths is uniting with sponsoring companies as a seamless team that makes well-thought-through decisions on time.

BTIG

BIO

Leveraging BTIG’s full resources, our Healthcare Investment Banking Group works alongside established and emerging, private and public healthcare companies to help them grow and capitalize on valuable market opportunities. With seasoned healthcare-focused banking professionals in Boston, New York and San Francisco, we collaborate with clients to execute transformative transactions.

We deliver deep sector and transactional expertise across biotechnology, life science and diagnostic tools, medical technology and specialty pharmaceuticals. Regardless of the stage of their development, BTIG’s knowledgeable, senior team delivers operational and financial guidance to corporate clients across the healthcare spectrum. And, with our extensive industry relationships, we offer investor perspective and insights that help adjust and evolve corporate strategy.